EP Patent

EP0577215A1 — Surface modified anticancer nanoparticles

Assigned to Nanosystems LLC · Expires 1994-01-05 · 32y expired

What this patent protects

Dispersible particles consisting essentially of a crystalline anticancer agent having a surface modifier adsorbed on the surface thereof in an amount sufficient to maintain an effective average particle size of less than about 1000 nm. Anticancer compositions comprising the parti…

USPTO Abstract

Dispersible particles consisting essentially of a crystalline anticancer agent having a surface modifier adsorbed on the surface thereof in an amount sufficient to maintain an effective average particle size of less than about 1000 nm. Anticancer compositions comprising the particles exhibit reduced toxicity and/or enhanced efficacy, and can be administered by intravenous injection.

Drugs covered by this patent

Patent Metadata

Patent number
EP0577215A1
Jurisdiction
EP
Classification
—
Expires
1994-01-05
Drug substance claim
No
Drug product claim
No
Assignee
Nanosystems LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.